Introduction
Drug utilization studies are usually conducted to understand medicine usage patterns in a hospital setting, to facilitate improvements, and to provide an uninterrupted supply of commonly used medicines. The research also helps minimize the risk of adverse events and drug interactions, which can contribute to better therapeutic outcomes. Regular prescription audits also help in evaluating and, if necessary, in suggesting changes in prescribing practices to facilitate rational and cost-effective medical care.
Major concerns during surgical procedures include anxiety among patients, post-operative pain, post-operative nausea and vomiting, and the risk of aspiration pneumonitis. Preanesthetic medicines are generally given to avoid the adverse events associated with general anesthesia, facilitate surgery, and reduce the risk of post-operative complications [1] . The agents used as pre-anesthetic medications include agents to reduce gastric acidity, benzodiazepines [2] [3] , anticholinergic agents [4] [5] , antiemetics [6] , pentazocine [7] , and opioid analgesics. Pre-anesthetic agents are given about half an hour to one hour before an anesthetic agent, with the objective of making anesthesia safer and more agreeable to the patient. Preanesthetic medications are used depending on the patient's clinical status and the type and duration of operation. Drug utilization studies on pre-anesthetic medicines in India are limited. This study was conducted to understand the prescription and utilization patterns of preanesthetic medications for different surgical procedures.
Materials And Methods
In this cross-sectional, pharmacoepidemiological, and observational study, patients of both sexes and of all age groups receiving pre-anesthetic medication for surgical procedures in routine or emergency conditions were included.
The prescription and utilization of pre-anesthetic medicines in all patients undergoing surgeries under general anesthesia for various indications were recorded during a six-month period. After recording the patient's demographic data, the indications of surgery and the details of the pre-anesthetic medications used were recorded. The study was initiated after receiving approval from the institutional ethics committee.
Statistical analysis
Categorical data are presented as numbers and percentages, while continuous data are presented as mean and standard deviations (SD).
Results
A total of 110 patients (57.27% males) were enrolled in this study. The mean age of study participants was 42.36 (+18.36) years. The minimum age of study participants was 3 days and the maximum was 76 years ( A total of 103 (93.64%) patients received midazolam, while seven (6.36%) patients did not receive it (Figure 2) . Overall, 89.09% patients received a 1 mg dose of midazolam, while 0.5 mg was used in 4.55% patients (Figure 2 ).
FIGURE 2: Use of midazolam in the study
In 86 patients (78.18%), a 15 mg dose of pentazocine was used, while in other patients, a smaller dose was used. Among the anticholinergic agents, glycopyrrolate was used in 76 patients (69.09%), while in eight patients (7.27%), atropine was used. In 26 patients (23.64%), no anticholinergic agent was used ( Figure 3 ).
FIGURE 3: Usage of anticholinergic agents as pre-anesthetic medication
Out of the eight patients to whom atropine was administered, a 100 mcg dose was used in one patient, while in other patients, a smaller dose was used.
Glycopyrrolate was administered as a 0.2 mg dose to 74 patients (97.37%), while 0.1 mg was administered to two patients (2.63%).
Fentanyl was used in 23 patients. The major indications for the use of fentanyl were carcinoma -8 (34.8%), perforation peritonitis -4 (17.4%), and surgery for intestinal obstruction -3 (13%).
Other indications for the use of fentanyl are given in Table 3 . Out of eight patients to whom fentanyl was administered, three (35.5%) had cancer of the buccal mucosa, while malignant ovarian tumor, cancer of the tongue, lip, and esophagus, and cholangiocarcinoma were present in one patient each ( Table 4) .
Indication N (%)
Cancer of buccal mucosa 3 (35.5%) 
Discussion
Drug utilization studies are important for scientific as well as administrative purposes in large hospital settings, especially tertiary care centers. Significant insights into the use of medicines, indications, side effects, and drug interactions can be obtained from such studies. There are limited data from Indian settings showing trends in the usage of pre-anesthetic medications in patients undergoing surgeries under general anesthesia. We performed a cross-sectional study in a tertiary healthcare setup to help understand the utilization of pre-anesthetic medicines.
Nausea and vomiting are one of the major concerns in patients undergoing surgery. The concern is because of two reasons: One, the morbidity it causes in patients, and two, the risk of surgical complications [6] . Several drugs, including antihistaminics, anticholinergics, dopamine antagonists, and phenothiazine derivatives, have been used in the management of postoperative nausea and vomiting. Unwanted side effects limit the use of most of these drugs [8] .
The introduction of 5-HT3 receptor antagonists is one of the major milestones in antiemetic therapy [9] [10] . These agents are significantly effective in the prevention of post-operative nausea and vomiting. Ondansetron, the first agent introduced in this class, is devoid of any significant effect on other receptors (e.g., dopamine, histamine, or sympathetic/parasympathetic receptors) apart from 5-HT3 [9] .
In our study, two of the most commonly used antiemetic agents were ondansetron and metoclopramide. The prophylactic administration of intravenous (IV) ranitidine and metoclopramide reduces the volume of gastric content and increases the gastric pH, reducing the risk of aspiration pneumonitis in patients receiving anesthesia [11] . In our study, all patients received metoclopramide plus ranitidine injections.
Benzodiazepines are used to reduce anxiety in patients undergoing surgery. Diazepam was the preferred agent for this purpose for several years. However, today, midazolam is preferred over diazepam because of its higher potency, faster onset of action, and shorter duration of action [2] . A study has shown that in patients between 60 and 69 years of age, 2 or 3 mg of intramuscular midazolam is an effective pre-anesthetic medication and does not cause severe drowsiness. However, in patients aged 70 years and above, it might cause severe drowsiness [3] . In our study, the most commonly used dose of midazolam was 1 mg. In this dose, midazolam was well-tolerated without significant concerns of drowsiness.
Intravenous pentazocine can be used preoperativelyto reduce intraoperative hemodynamic changes, pain following surgery, and fentanyl-induced cough [7] [8] [9] [10] [11] [12] . The combination of pentazocin-phenergan-midazolam is better than the ketamine-midazolam combination along with local anesthesia in terms of hemodynamic changes and provides a longer duration of analgesia. Similarly, patient satisfaction with the triple drug combination is also better than with the ketamine-midazolam combination for surgeries performed under monitored anesthesia care [13] . In our study, the use of pentazocine and midazolam was very common, but the use of phenergan was not.
Anticholinergic agents are routinely prescribed pre-anesthetic medications. Atropine and glycopyrrolate are two well-studied pre-anesthetic anticholinergic agents. Glycopyrrolate is more potent than atropine, and it consequently needs a lower dose. The other advantages of glycopyrrolate include a more-stable response in the cardiovascular system, less risk of bradycardia, and better control of oropharyngeal secretions during reversal [4] .
A comparative study showed a similar effect to that of ondansetron when using glycopyrrolate for nausea and vomiting during a cesarean section [6] .
Even in children, glycopyrrolate is the anticholinergic agent most commonly used as preanesthetic medication [5] [6] . Consistent with findings in the literature, glycopyrrolate was the most commonly used anticholinergic agent in our study. The use of glycopyrrolate was almost 10 times more common than that of atropine in the present study.
